000			03802nam a22003735i 4500
001			81423
003			ES-MaUEC
005			20230207040329.0
007			cr nn 008mamaa
008			150619s2015 gw | s |||| 0|eng d
020			_a9783319183657
024	7		_a10.1007/978-3-319-18365-7 _2doi
050		4	_aRC632.A5 _bN388 2015
245	1	0	_aNatural Compounds as Therapeutic Agents for Amyloidogenic Diseases _cedited by Neville Vassallo.
260			_aCham, Switzerland _bSpringer _c2015
300			_a1 recurso en línea (VII, 163 páginas) _b41 ilustraciones, 26 ilustraciones en color
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
490	0		_aAdvances in Experimental Medicine and Biology _x0065-2598 _v863
505	0		_aOlive Oil Phenols as Promising Multi-targeting Agents against Alzheimer's disease -- Alzheimerâ€{u3824}isease, Drosophila melanogaster and Polyphenols -- Biflavonoids as Potential Small Molecule Therapeutics for Alzheimerâ€{u3824}isease -- Natural Phenolic Compounds as Therapeutic and Preventive Agents for Cerebral Amyloidosis.-Â{u2CA1}ain Food for Alzheimer-free Ageing: Focus on Herbal Medicines -- Tea Polyphenols in Parkinsonâ€{u3824}isease -- The Effect of (-)-Epigallo-catechin-(3)-gallate on Amyloidogenic Proteins Suggests a Common Mechanism.
520	3		_aThis edited volume concerns a group of devastating neurological disorders that share a common pathological mechanism, namely the aggregation and deposition of insoluble, proteinaceous lesions, termed â€ãmyloidâ€{uE805}xamples of cerebral amyloid disorders include common neurodegenerative diseases like Alzheimerâ€{u3824}isease-related dementia and Parkinsonâ€{u3824}isease, as well as other less prevalent conditions like Huntingtonâ€{u3824}isease, cerebral amyloid angiopathy and the transmissible prion disorders. A disease-modifying therapeutic agent is still lacking for all these diseases, and there are no approved therapies that target amyloid formation directly. Nevertheless, a large and complex group of natural aromatic compounds known as polyphenols are rapidly emerging as potentially potent anti-amyloidogenic agents. This book collectively presents a considerable body of experimental and epidemiological evidence from peer-reviewed scientific publications that support a role for natural compounds and herbal extracts in the chemoprevention and therapy of amyloidogenic disorders. Each contribution is written by scientific experts in the relevant field; chapters are devoted to Mediterranean diet and olive oil phenols, traditional Chinese medicine, herbal extracts, polyphenols (with a particular emphasis on epigallocatechin-3-gallate) and bi-flavonoids, amongst others. The topic of this book is relevant to a wide audience, from academia and university students in the biological and chemical sciences, to physicians and allied health professionals, as well as people working in the nutraceutical industry.
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
988			_aEBOOK, EBSPRINGER, asignarmaterias_11febrero
650		7	_aFarmacia _2embne _9137891
650		0	_9146728 _aNeuroquímica
650		7	_aNutrición _2embne _9138371
700	1		_aVassallo, Neville _eeditor literario _993833 _0Local
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-18365-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b12900138 _b10-10-17 _c18-01-16
998			_am _a_alco _a_vill _b - - _cm _dz _e- _feng _ggw _h0
945			_aRC632.A5 N388 2015 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i1156975x _z06-04-17
999			_c81423 _d81423 _x1